Orange Book product · Brand (NDA)
EMEND
APREPITANT
At a glance
Jun 30, 2006
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 30, 2006
20 yr 3 mo ago
Today
Patent 8258132 expires
Listed drug product patent expiration.
Sep 26, 2027
in 1 yr 3 mo
Patent 8258132 expires
Listed drug product patent expiration.
Sep 26, 2027
in 1 yr 3 mo
Pharmaceutical detail
Active ingredient
APREPITANT
Strength
40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 021549
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2022APONVIEBrand (NDA)
NDA 216457 · HERON THERAPS INC
- 2017CINVANTIBrand (NDA)
NDA 209296 · HERON THERAPS INC
- 2015EMENDBrand (NDA)
NDA 207865 · MSD MERCK CO
- 2026APREPITANTGeneric (ANDA)
ANDA 218851 · MYLAN
- 2020APREPITANTGeneric (ANDA)
ANDA 211835 · TORRENT
- 2017APREPITANTGeneric (ANDA)
ANDA 207777 · GLENMARK SPECLT
- 2012APREPITANTGeneric (ANDA)
ANDA 090999 · SANDOZ
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8258132 | Sep 26, 2027 | in 1 yr 3 mo | ProductU-901 |
| 8258132 | Sep 26, 2027 | in 1 yr 3 mo | ProductU-1743 |

